Keisuke Inoue

Augmented reduction of islet β‐cell mass in Goto‐Kakizaki rats fed high‐fat diet and its suppression by pitavastatin treatment

S. Yagihashi, H. Mizukami, K. Sawanobori, 2011, Journal of diabetes investigation.

Influence of long term administration of tofogliflozin on chronic inflammation of visceral adipose tissue in mice with obesity induced by a high-fat diet

Wataru Yano, Y. Katsumata, J. Endo, 2019 .

Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance

Jose-Luiz Figueiredo, Wataru Yano, M. Aikawa, 2015, PloS one.

Abstract 12867: The Mechanism of K-877, a Highly Potent and Selective Pparalpha Modulator, on Regulation of Synthesis, Secretion and Metabolism of Triglycerides and Cholesterol

Y. Yoshinaka, Keisuke Inoue, S. Goto, 2013 .

K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models.

S. Itoh, Hideo Suzuki, S. Kondo, 2012, European Journal of Pharmacology.

Metabolic effects of Tofogliflozin are efficiently enhanced with appropriate dietary carbohydrate ratio and are distinct from carbohydrate restriction

Wataru Yano, T. Hosaka, Hideyuki Kobayashi, 2018, Physiological reports.

Mechanism of lipid‐lowering action of the dipeptidyl peptidase‐4 inhibitor, anagliptin, in low‐density lipoprotein receptor‐deficient mice

M. Goto, Wataru Yano, K. Kaku, 2016, Journal of diabetes investigation.

Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists.

B. Staels, J. Fruchart, Keisuke Inoue, 2007, Bioorganic & medicinal chemistry letters.